Precision targeting of the PTEN–miRNA–PTENP1 axis is important for the regulation of PTEN and may present as a viable alternative therapy to increase endogenous wild-type PTEN in tumours shown to have reduced PTEN levels. The gene discussed is PTENP1; the disease is neoplasm.